BACKGROUND: Ultrasonography (USG) and @entity1136 sestamibi (MIBI) scintigraphy are commonly used imaging modalities in the era of @entity3 ( @entity3 ) for @entity459 ( @entity459 ). However, their relative importance and actual contribution to @entity3 have not been prospectively assessed. METHODS: A total of 100 consecutive @entity459 @entity1 planning for @entity3 were recruited. Both USG and MIBI findings were correlated with intraoperative findings and postoperative outcome. Clinicopathologic factors were examined for potential association with a correct localizing result. RESULTS: Thirty @entity1 and 70 @entity1 (age range 13 to 93 years [median 55.5]) were included in the study. The final pathology included 98 @entity1 with solitary @entity652 @entity1 with @entity66 . The sensitivities, accuracies, and positive predicted values for USG and MIBI alone were 57% vs 89%, 56% vs 85%, and 97% vs 94%, respectively. Correctly localized adenomas were significantly heavier than incorrectly localized ones. CONCLUSIONS: MIBI is preferred over USG in @entity459 @entity1 planning for @entity3 . Weight of @entity652 appeared to be the only clinicopathologic factor determining localization accuracy.

A prospective evaluation of preoperative localization by @entity1136 sestamibi scintigraphy and ultrasonography in XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'men'] @entity1136 :: ('MESH:D013667', 'Chemical') :: ['technetium-99m'] @entity459 :: ('MESH:D049950', 'Disease') :: ['primary hyperparathyroidism', 'pHPT'] @entity66 :: ('MESH:D004194', 'Disease') :: ['multiglandular disease'] @entity3 :: ('MESH:D009362', 'Disease') :: ['MIP', 'minimally invasive parathyroidectomy'] @entity652 :: ('MESH:D000236', 'Disease') :: ['adenoma and 2', 'adenoma']
@entity459 :: (MESH:D049950,Disease) :: ['primary hyperparathyroidism']
